[2P-0252] Nuclear phosphorylated Dicer contributes to metabolic switch and gemcitabine resistance of pancreatic cancer

〇Ching-Feng Chiu^1,2、Yen-Hao Su^3,4,5、Chia-Ying Lin¹、Ji Min Park^1,2、Chien-Chao Chiu⁶、Shao-Wen Hung^6,7、Hsin-An Chen^3,4、Ming-Te Huang^3,4 (1.Grad. Inst. of Metab. & Obes. Sci., Coll. of Nutr., Taipei Med. Univ.、2.Sch. of Nutr. and Heal. Sci., Coll. of Nutr., Taipei Med. Univ.、3.Div. of Gen. Surg., Dept. of Surg., Shuang Ho Hosp., Taipei Med. Univ.、4.Dept. of Surg., Sch. of Med., Coll. of Med., Taipei Med. Univ.、5.Metab. & Weight Mgmt. Ctr., Shuang Ho Hosp., Taipei Med. Univ.、6.Div. of Animal Res., Animal Tech. Lab., Agric. Tech. Res. Inst.、7.Nursing Dept. of Yuanpei Univ., Xiang shan)

Dicer、gemcitabine、pyruvate kinase M2、pancreatic cancer